medigraphic.com
ISSN 0035-0052 (Print)

2022, Number 4

<< Back Next >>

Rev Mex Pediatr 2022; 89 (4)

Status dystonicus in a patient with cerebral palsy and COVID-19

Rojas-Cerón C, Núñez-Arboleda AF, Arce-Gálvez L

Language: Spanish
References: 11
Page: 170-172
PDF size: 193.41 Kb.


ABSTRACT

Introduction: status dystonicus (SD) is a rare condition characterized by generalized and intense exacerbation of muscle contractions. Objective: to present a pediatric patient with SD associated with COVID-19. Case report: 3-year old male with cerebral palsy. He was admitted to the emergency room after four days with respiratory symptoms, which were accompanied by increased muscle tone, generalized dystonia, and febrile seizures. In laboratory tests, COVID-19 was confirmed, as well as an elevation of creatine phosphokinase (CPK), 16,000 U/L. Diagnosis of SD is established, recovering after receiving medical management. Conclusion: SD can cause serious complications, so it is essential to identify possible triggers in patients with greater susceptibility.


REFERENCES

  1. Termsarasab P, Frucht SJ. Dystonic storm: a practical clinical and video review. J Clin Mov Disord. 2017; 4: 10. Disponible en: https://doi.org/10.1186/s40734-017-0057-z

  2. Manji H, Howard RS, Miller DH, Hirsch NP, Carr L, Bhatia K et al. Status dystonicus: the syndrome and its management. Brain. 1998; 121(2): 243-252. Disponible en: https://doi.org/10.1093/brain/121.2.243

  3. Grosso S, Verrotti A, Messina M, Sacchini M, Balestri P. Management of status dystonicus in children. Eur J Paediatr Neurol. 2012; 16(4): 390-395. Disponible en: https://doi.org/10.1016/j.ejpn.2011.12.007

  4. Allen NM, Lin J-P, Lynch T, King MD. Status dystonicus: a practice guide. Dev Med Child Neurol. 2014; 56: 105-112. Disponible en: https://doi.org/10.1111/dmcn.12339

  5. Jankovic J, Penn AS. Severe dystonia and myoglobinuria. Neurology. 1982; 32: 1195-1197. Disponible en: https://doi.org/10.1212/wnl.32.10.1195

  6. Mariotti P, Fasano A, Contarino MF, Della Marca G, Piastra M, Genovese O et al. Management of status dystonicus: our experience and review of the literature. Mov Disord. 2007; 22: 963-968. Disponible en: https://doi.org/10.1002/mds.21471

  7. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77: 683-690. Disponible en: https://doi.org/10.1001/jamaneurol.2020.1127

  8. Cagnazzo F, Arquizan C, Derraz I, Dargazanli C, Lefevre P-H, Riquelme C et al. Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature. J Neurol. 2021; 268: 2656-2665. Disponible en: https://doi.org/10.1007/s00415-020-10285-9

  9. Pleasure SJ, Green AJ, Josephson SA. The spectrum of neurologic disease in the severe acute respiratory syndrome coronavirus 2 pandemic infection: neurologists move to the frontlines. JAMA Neurol. 2020; 77: 679-680. Disponible en: https://doi.org/10.1001/jamaneurol.2020.1065

  10. Lumsden DE, Lundy C, Fairhurst C, Lin J-P. Dystonia severity action plan: a simple grading system for medical severity of status dystonicus and life-threatening dystonia. Dev Med Child Neurol. 2013; 55: 671-672. Disponible en: https://doi.org/10.1111/dmcn.12108

  11. Fasano A, Ricciardi L, Bentivoglio AR, Canavese C, Zorzi G, Petrovic I et al. Status dystonicus: Predictors of outcome and progression patterns of underlying disease. Mov Disord. 2012; 27: 783-788. Disponible en: https://doi.org/10.1002/mds.24981




2020     |     www.medigraphic.com